• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟体外筛选中溶剂和缓冲液允许限度参考文件

A reference document on Permissible Limits for solvents and buffers during in vitro antimalarial screening.

机构信息

Pillar of Engineering Product Development (EPD), Singapore University of Technology and Design (SUTD), Singapore, 487372, Singapore.

Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.

出版信息

Sci Rep. 2018 Oct 8;8(1):14974. doi: 10.1038/s41598-018-33226-z.

DOI:10.1038/s41598-018-33226-z
PMID:30297791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6175914/
Abstract

Antimalarial drug discovery expands on targeted and phenotype-based screening of potential inhibitory molecules to ascertain overall efficacy, phenotypic characteristics and toxicity, prior to exploring pharmacological optimizations. Candidate inhibitors may have varying chemical properties, thereby requiring specific reconstitution conditions to ensure solubility, stability or bioavailability. Hence, a variety of solvents, buffers, detergents and stabilizers become part of antimalarial efficacy assays, all of which, above certain threshold could interfere with parasite viability, invasion or red blood cell properties leading to misinterpretation of the results. Despite their routine use across malaria research laboratories, there is no documentation on non-toxic range for common constituents including DMSO, glycerol, ethanol and methanol. We herein constructed a compatibility reference guide for 14 such chemicals and estimated their Permissible Limit against P. falciparum asexual stages at which viability and replication of parasites are not compromised. We also demonstrate that at the estimated Permissible Limit, red blood cells remain healthy and viable for infection by merozoites. Taken together, this dataset provides a valuable reference tool for the acceptable concentration range for common chemicals during in vitro antimalarial tests.

摘要

抗疟药物的发现扩展到针对潜在抑制分子的靶向和表型筛选,以确定整体疗效、表型特征和毒性,然后再探索药理学优化。候选抑制剂可能具有不同的化学性质,因此需要特定的复溶条件以确保溶解度、稳定性或生物利用度。因此,各种溶剂、缓冲液、清洁剂和稳定剂成为抗疟疗效测定的一部分,所有这些物质在超过一定阈值时都可能干扰寄生虫的生存能力、入侵能力或红细胞特性,从而导致对结果的误解。尽管这些物质在疟疾研究实验室中经常使用,但对于包括 DMSO、甘油、乙醇和甲醇在内的常见成分的无毒范围,尚无文献记载。我们在此构建了 14 种此类化学物质的兼容性参考指南,并估计了它们对无鞭毛体寄生虫无性阶段的允许极限,在此极限下,寄生虫的生存能力和复制能力不会受到损害。我们还证明,在估计的允许极限下,红细胞保持健康和活力,可被裂殖子感染。总之,该数据集为体外抗疟试验中常见化学物质的可接受浓度范围提供了有价值的参考工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/f20c89a643f8/41598_2018_33226_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/02cb9270c718/41598_2018_33226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/fe02f994c85d/41598_2018_33226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/1ac6cc3ed795/41598_2018_33226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/f20c89a643f8/41598_2018_33226_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/02cb9270c718/41598_2018_33226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/fe02f994c85d/41598_2018_33226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/1ac6cc3ed795/41598_2018_33226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf8c/6175914/f20c89a643f8/41598_2018_33226_Fig4_HTML.jpg

相似文献

1
A reference document on Permissible Limits for solvents and buffers during in vitro antimalarial screening.抗疟体外筛选中溶剂和缓冲液允许限度参考文件
Sci Rep. 2018 Oct 8;8(1):14974. doi: 10.1038/s41598-018-33226-z.
2
Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.大环内酯类药物可迅速抑制人类疟原虫恶性疟原虫对红细胞的入侵。
BMC Biol. 2015 Jul 18;13:52. doi: 10.1186/s12915-015-0162-0.
3
Antimalarial and safety evaluation of Pluchea lanceolata (DC.) Oliv. & Hiern: in-vitro and in-vivo study.黄花蒿(DC.)Oliv. 和 Hiern 的抗疟和安全性评价:体外和体内研究。
J Ethnopharmacol. 2013 Oct 7;149(3):797-802. doi: 10.1016/j.jep.2013.08.003. Epub 2013 Aug 14.
4
Phenotypic Screens in Antimalarial Drug Discovery.抗疟药物研发中的表型筛选
Trends Parasitol. 2016 Sep;32(9):697-707. doi: 10.1016/j.pt.2016.04.014. Epub 2016 May 27.
5
4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.4-硝基苯乙烯基喹啉是一种抗疟药物,可抑制恶性疟原虫无性生命周期的多个阶段。
Int J Parasitol Drugs Drug Resist. 2017 Apr;7(1):120-129. doi: 10.1016/j.ijpddr.2017.02.002. Epub 2017 Feb 21.
6
Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.利用细胞术筛选和评估恶性疟原虫裂殖子逸出和入侵的抑制剂
Methods Mol Biol. 2013;923:523-34. doi: 10.1007/978-1-62703-026-7_36.
7
Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen.二氨基萘醌对恶性疟原虫配子体具有强效杀灭活性,这是在抗疟化合物筛选中确定的先导抗疟化学类型。
Antimicrob Agents Chemother. 2015 Mar;59(3):1389-97. doi: 10.1128/AAC.01930-13. Epub 2014 Dec 15.
8
Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.针对三种不同寄生虫生活阶段的具有抗疟活性的小分子的表型筛选。
Methods Mol Biol. 2018;1787:41-52. doi: 10.1007/978-1-4939-7847-2_3.
9
[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].[来自阿比让(科特迪瓦)的恶性疟原虫分离株对奎宁、青蒿琥酯和氯喹的体外敏感性]
Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103.
10
A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.一组具有阻断恶性疟原虫传播潜力的新化学起始点,用于抗疟药物发现。
PLoS One. 2015 Aug 28;10(8):e0135139. doi: 10.1371/journal.pone.0135139. eCollection 2015.

引用本文的文献

1
Antimalarial Activity of Aqueous Extracts of Nasturtium ( L.) and Benzyl Isothiocyanate.荭草(L.)和苄基异硫氰酸酯水提取物的抗疟活性。
Molecules. 2024 May 15;29(10):2316. doi: 10.3390/molecules29102316.
2
Antiplasmodial Activity Evaluation of a Bestatin-Related Aminopeptidase Inhibitor, Phebestin.苯丁抑制肽类氨肽酶抑制剂 phebestin 的抗疟原虫活性评价
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0160622. doi: 10.1128/aac.01606-22. Epub 2023 Jun 14.
3
Eryptosis and Malaria: New Experimental Guidelines and Re-Evaluation of the Antimalarial Potential of Eryptosis Inducers.

本文引用的文献

1
Targeted Phenotypic Screening in and Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules.在[具体内容缺失]和[具体内容缺失]中的靶向表型筛选揭示了疟疾药物研发项目疟疾盒分子的新型作用模式。
mSphere. 2018 Jan 17;3(1). doi: 10.1128/mSphere.00534-17. eCollection 2018 Jan-Feb.
2
A portable image-based cytometer for rapid malaria detection and quantification.一种用于快速疟疾检测和定量的便携式基于图像的细胞仪。
PLoS One. 2017 Jun 8;12(6):e0179161. doi: 10.1371/journal.pone.0179161. eCollection 2017.
3
Synthesis and in vitro evaluation of hydrazinyl phthalazines against malaria parasite, Plasmodium falciparum.
红细胞外渗与疟疾:新的实验指南和红细胞外渗诱导剂抗疟潜力的重新评估。
Front Cell Infect Microbiol. 2021 Mar 12;11:630812. doi: 10.3389/fcimb.2021.630812. eCollection 2021.
4
Diamond Magnetic Microscopy of Malarial Hemozoin Nanocrystals.疟原虫疟色素纳米晶体的金刚石磁显微镜。
Phys Rev Appl. 2019 Mar;11(3). doi: 10.1103/PhysRevApplied.11.034029. Epub 2019 Mar 12.
肼基酞嗪对疟原虫恶性疟原虫的合成及体外评价
Bioorg Med Chem Lett. 2016 Jul 15;26(14):3300-3306. doi: 10.1016/j.bmcl.2016.05.049. Epub 2016 May 18.
4
Artemisinin anti-malarial drugs in China.中国的青蒿素抗疟药物。
Acta Pharm Sin B. 2016 Mar;6(2):115-24. doi: 10.1016/j.apsb.2016.01.008. Epub 2016 Feb 18.
5
Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission.来自恶性疟原虫低传播地区血清学数据的多重比较分析。
Malar J. 2015 Nov 4;14:436. doi: 10.1186/s12936-015-0955-1.
6
Single-cell evaluation of red blood cell bio-mechanical and nano-structural alterations upon chemically induced oxidative stress.化学诱导氧化应激下红细胞生物力学和纳米结构改变的单细胞评估
Sci Rep. 2015 May 7;5:9768. doi: 10.1038/srep09768.
7
Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in vitro assays.抗疟药物双氢青蒿素在生理相关条件下的稳定性:对临床治疗、药代动力学及体外试验的影响
Antimicrob Agents Chemother. 2015 Jul;59(7):4046-52. doi: 10.1128/AAC.00183-15. Epub 2015 Apr 27.
8
Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.通过筛选抗疟化合物聚焦文库鉴定恶性疟原虫己糖转运蛋白PfHT的选择性抑制剂
PLoS One. 2015 Apr 20;10(4):e0123598. doi: 10.1371/journal.pone.0123598. eCollection 2015.
9
A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.一种化学蛋白质组学方法,利用光交联和点击化学在恶性疟原虫中寻找抗疟临床候选药物阿比噻唑的药理学靶点。
PLoS One. 2014 Dec 3;9(12):e113918. doi: 10.1371/journal.pone.0113918. eCollection 2014.
10
Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria.静脉注射亚甲蓝、静脉注射青蒿琥酯及其联合用药在疟疾临床前模型中的疗效。
Malar J. 2014 Oct 21;13:415. doi: 10.1186/1475-2875-13-415.